SUNRISE MEDICAL TECHNOLOGIAS Q1-2026 supplier risk profile: single-source China imports, B-grade compliance score.
SUNRISE MEDICAL TECHNOLOGIAS processed 120 shipments in Q1 2026, sourcing from a single supplier across one country. All imports originated from China, representing 100% of the company's inbound volume. The dominant supplier is HL SHEN ZHEN, which accounted for the entire shipment count. No HS classification data is available for this period.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
SUNRISE MEDICAL TECHNOLOGIAS registered zero sanctions watchlist matches in Q1 2026. No suppliers in the company's supply chain show documented forced-labor exposure under the Uyghur Forced Labor Prevention Act framework.
1 distinct tier-1 suppliers in Q1 2026
| HL SHEN ZHEN | China | 120 |
Share of Q1 2026 inbound shipments by source country
39 tier-2 + 87 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.